These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34689383)

  • 1. Decreased frequency of transplantation and lower post-transplant survival free of re-transplantation in LVAD patients with the new heart transplant allocation system.
    Jani M; Lee S; Acharya D; Hoeksema S; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2022 Jan; 36(1):e14493. PubMed ID: 34689383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
    Mullan CW; Chouairi F; Sen S; Mori M; Clark KAA; Reinhardt SW; Miller PE; Fuery MA; Jacoby D; Maulion C; Anwer M; Geirsson A; Mulligan D; Formica R; Rogers JG; Desai NR; Ahmad T
    JACC Heart Fail; 2021 Jun; 9(6):420-429. PubMed ID: 33714748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Year Left Ventricular Assist Device Outcomes and Strategy After Heart Transplant Allocation Score Change.
    Agronin J; Brown M; Calvelli H; Zhao H; Rakita V; Toyoda Y; Kashem MA
    Am J Cardiol; 2024 Sep; 226():1-8. PubMed ID: 38972536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation.
    Steinberg RS; Okoh AK; Wang J; Patel KJ; Gangavelli A; Nayak A; Ko YA; Gupta D; Daneshmand M; Vega JD; Morris AA
    JACC Heart Fail; 2024 Aug; 12(8):1459-1469. PubMed ID: 38180429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS - OPTN/UNOS data analysis.
    Alba AC; Kirklin JK; Cantor RS; Deng L; Ross HJ; Jacobs JP; Rao V; Hanff TC; Stehlik J
    J Heart Lung Transplant; 2023 Nov; 42(11):1587-1596. PubMed ID: 37385418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
    Uriel MH; Clerkin KJ; Takeda K; Naka Y; Sayer GT; Uriel N; Topkara VK
    J Heart Lung Transplant; 2023 Jan; 42(1):124-133. PubMed ID: 36272893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system.
    Gonzalez MH; Acharya D; Lee S; Leacche M; Boeve T; Manandhar-Shrestha N; Jovinge S; Loyaga-Rendon RY
    J Heart Lung Transplant; 2021 Feb; 40(2):149-157. PubMed ID: 33277169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability.
    Cogswell R; Duval S; John R
    Int J Cardiol; 2018 Oct; 268():51-54. PubMed ID: 29803342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Opportunities for Transplantation for Women in the New Heart Allocation System.
    Defilippis EM; Truby LK; Clerkin KJ; Donald E; Sinnenberg L; Varshney AS; Cogswell R; Kittleson MM; Haythe JH; Givertz MM; Hsich EM; Agarwal R; Topkara VK; Farr M
    J Card Fail; 2022 Jul; 28(7):1149-1157. PubMed ID: 35470056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 2018 allocation system change on outcomes in patients with durable left ventricular assist device as bridge to transplantation: A UNOS registry analysis.
    Hess NR; Ziegler LA; Keebler ME; Hickey GW; Kaczorowski DJ
    J Heart Lung Transplant; 2023 Jul; 42(7):925-935. PubMed ID: 36973093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation.
    Okoh AK; Selevanny M; Singh S; Hirji S; Singh S; Al Obaidi N; Lee LY; Camacho M; Russo MJ
    ESC Heart Fail; 2020 Oct; 7(5):2744-2751. PubMed ID: 32627939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing Risks to Transplant in Bridging With Continuous-flow Left Ventricular Assist Devices.
    Bakir NH; Finnan MJ; Itoh A; Pasque MK; Ewald GA; Kotkar KD; Damiano RJ; Moon MR; Hartupee JC; Schilling JD; Masood MF
    Ann Thorac Surg; 2022 Oct; 114(4):1276-1283. PubMed ID: 34808111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.
    Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Trinh PN; Yuzefpolskaya M; Farr MA; Naka Y; Colombo PC; Topkara VK
    Circ Heart Fail; 2018 Apr; 11(4):e004586. PubMed ID: 29666073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable Left Ventricular Assist Device as a Bridge to Heart Transplantation Under the New Donor Heart Allocation System.
    Nordan T; Critsinelis AC; Ortoleva J; Kiernan MS; Vest A; DeNofrio D; Chen FY; Couper GS; Kawabori M
    ASAIO J; 2022 Jul; 68(7):890-898. PubMed ID: 34711746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation.
    Uriel N; Jorde UP; Woo Pak S; Jiang J; Clerkin K; Takayama H; Naka Y; Schulze PC; Mancini DM
    J Heart Lung Transplant; 2013 Feb; 32(2):188-95. PubMed ID: 23352392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.